Clairfield International was ranked at the top of the league tables for financial advisory of worldwide midmarket transactions and of transactions in healthcare according to the July report by Thomson Reuters. Clairfield is uniquely positioned in the tables as one of a handful of independent investment banks to achieve such a high ranking. Earlier this year in Thomson Reuters research focusing on other sectors, Clairfield placed in the top 10 for financial advisory to the industrial, retail, consumer staples, and materials sectors.

Clairfield has closed 11 deals so far this year in healthcare sub-sectors that range from residential care to practice management software. The healthcare group also has a robust pipeline with important international deal closings expected before year end.

Clairfield’s healthcare team is led by Jack Helm in Frankfurt and Dagmar Enklaar in Amsterdam. In addition, it has the support of senior advisors from industry including a healthcare board led by partner Dr. Fie Astrup in Copenhagen. The board, composed of leading figures in the  healthcare industry, is instrumental in providing insight and perspective on biotechnology and medical devices.

“Our worldwide sector expertise underpins our local and crossborder transactions at all stages of the process giving midmarket clients access to knowledge from sector experts around the globe. That knowledge extends to corporate access,  to understanding valuations and addressing critical issues in M&A execution, all the way to a successful transaction,” says Clairfield chairman Alex Klemm.

See the league tables here:

Thomson Reuters EMEA Mid-Market Insight July 2018